Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and phenotypic heterogeneity continue to pose major challenges for the genomics research community investigating interstitial lung disease.1
The Lancet Respiratory Medicine published a clinical update in Critical Care on 27 Jan 2026.
The item focuses on Telomere length, common variants, and rare variants in IPF: a trio of key risk determinants.
Review the original article for the full source wording and details.